SCHEMBL7335965

SCHEMBL7335965

N#Cc1cccc(CCC(=O)CCc2cccc(C#N)c2)c1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 4/20 0.57
▸ FFAR4 Q5NUL3 1/20 0.57
▸ CNR1 P21554 1/20 0.50
▸ MEP1A Q16819 1/20 0.50
▸ MEP1B Q16820 1/20 0.50
▸ LMNA P02545 1/20 0.48
▸ GLA P06280 1/20 0.47
▸ GSK3B P49841 2/20 0.47
▸ FOLH1 Q04609 1/20 0.47
▸ ERCC1 P07992 1/20 0.46
▸ ERCC4 Q92889 1/20 0.46
▸ HTR2B P41595 1/20 0.45
▸ VNN1 O95497 2/20 0.45
▸ KCNJ1 P48048 1/20 0.44
▸ KCNH2 Q12809 1/20 0.44
▸ IDH1 O75874 1/20 0.43
▸ PLA2G10 O15496 1/20 0.43
▸ PLA2G2A P14555 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3491515 0.88 FFAR1 (0.72) FFAR1FFAR4CNR1LMNAPLA2G10
SCHEMBL934610 0.86 FFAR1 (0.55) FFAR1FFAR4CNR1MEP1AMEP1B
SCHEMBL2411845 0.86 FFAR1 (0.55) FFAR1FFAR4CNR1MEP1AMEP1B
SCHEMBL6364918 0.86 FFAR1 (0.55) FFAR1FFAR4CNR1MEP1AMEP1B
SCHEMBL7421178 0.84 FFAR1 (0.50) FFAR1FFAR4CNR1MEP1AMEP1B
SCHEMBL27322168 0.83 FFAR1 (0.52) FFAR1FFAR4CNR1MEP1AMEP1B
SCHEMBL2154019 0.82 GLA (0.53) FFAR1FFAR4CNR1MEP1AMEP1B
SCHEMBL3926844 0.82 FFAR1 (0.54) FFAR1FFAR4CNR1MEP1AMEP1B
SCHEMBL3109008 0.82 FFAR1 (0.54) FFAR1FFAR4CNR1MEP1AMEP1B
SCHEMBL7055202 0.82 FFAR1 (0.51) FFAR1FFAR4CNR1MEP1AMEP1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0771196-B1 EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS LILLY CO ELI (US) 1999-12-08 — — EP disclosed
US-5717109-A CARBOXYCYCLOPROPYL GLYCINE DERIVATIVES; USEFUL FOR TREATMENT OF ACUTE OR CHRONIC NEURODEGENERATIVE CONDITIONS, AND AS ANTIPSYCHOTIC, ANTICONVULSANT, ANALGESIC, ANXIOLYTIC, ANTIDEPRESSANT AND ANTI-EMETIC AGENTS ELI LILLY AND COMPANY (US) 1998-02-10 — — US disclosed
EP-0771196-A4 EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS LILLY CO ELI (US) 1997-09-03 — — EP disclosed
EP-0771196-A1 EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 1997-05-07 — — EP disclosed
WO-1996007405-A1 EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 1996-03-14 — — WO disclosed
Send feedback